To clarify for you,

There are definitely items that will contribute to Q2 that dont show in Q1.

-kaitest online sales

-start of AC referral partnership

-continued private sector testing

- possible initial orders from Pharmachoice group partners

 Also, there are 2 functioning paramed clinics in Canada and still 1 SVH clinic in AZ.

We all just got a taste of over estimating or misreading revenue.  I would encourage not to do that in an opposite fashion either.   Q2 has more revenue streams active than Q1.    

And beyond the lower than anticipated revenues, the numbers are still fantastic.  

It's just that this filet mignon of a report seems to have been presented on a dirty plate.  It doesn't change the fact that the steak is excellent.   So next time, we get a clean plate, and take a bite.